Clinical trials supporting the use of BioGaia probiotics
L. reuteri Protectis, Prodentis, Pharax, Gastrus and Osfortis
BioGaia’s probiotic products with L. reuteri are among the most scientifically well-documented probiotics in the world with regard to both efficacy and safety.
BioGaia’s different strains of L. reuteri have been studied in more than 260 clinical trials involving over 22,000 people of all ages (Dec 2023).
In the past decade, research on bacteria and their significance to our health has increased. At BioGaia, we have been researching Limosilactobacillus reuteri (formerly Lactobacillus reuteri) for more than 30 years. During the years, we built a unique research network of specialists at research institutes worldwide. Together we have learned and gained knowledge about several L. reuteri bacteria strains for various conditions.
L. reuteri Protectis, Prodentis, Pharax, Gastrus and Osfortis
57
Infants 0-12 months
28
Toddlers 13-36 months
44
Children 3-18 years
137
Adults >18 years
Stay informed on the latest research within the probiotic field!
Subscribe to receive quarterly updates on our latest research developments, clinical studies, etc.